Moreover, it also decreases the phosphorylation of AKT (Ser473), which is normally hyperactivated in NSCLC, potentially explaining its ability to inhibit growth through AKT signaling [91]. The gene discussed is AKT1; the disease is non-small cell lung carcinoma.